Table 5.
Definition | |
---|---|
Diuretic-resistant ascites | Ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of a lack of response to sodium restriction and diuretic treatment |
Diuretic-intractable ascites | Ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage |
Requisites | |
Treatment duration | Intensive diuretic therapy (spironolactone 400 mg/day and furosemide 160 mg/day) for at least 1 week and on a salt-restricted diet of less than 5 g/day |
Response of therapy | Mean weight loss of <800 g over 4 days and urinary sodium output less than the sodium intake |
Early ascites recurrence | Recurrence of grade 2-3 ascites within 4 weeks of initial mobilization |
Diuretic-induced complications | Hepatic encephalopathy: development of encephalopathy in the absence of any other precipitating factor |
Renal impairment: >0.3 mg/dL increase of sCr within 48 hours of baseline or 1.5-fold increase within 1 week | |
Hyponatremia: decrease of serum sodium by >10 mEq/L to serum sodium of <125 mEq/L | |
Hypo- or hyperkalemia: change in serum potassium to <3 mmol/L or >6 mmol/L |
sCr, serum creatinine.